Healthcare Triangle announces $15.2 million PIPE offering
The PIPE offering consists of 36,190,476 units
The PIPE offering consists of 36,190,476 units
We will continue to expand our range of purified excipients, offering pharmaceutical companies a dependable partner
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
Hikal Limited announces the completion of the US Food and Drug Administration (USFDA) inspection at its Jigani unit, Bengaluru
Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)
The inspection was carried out from January 28 to February 1, 2025
Subscribe To Our Newsletter & Stay Updated